Both in Biotechnology
Metagenomi Therapeutics vs Cel-Sci
Over the past year MGX returned −67.7% and CVM returned −81.3%; their daily moves had a correlation of 0.10.
MGX −67.7% CVM −81.3%Growth of $1, one year, split-adjusted
| Metric | MGX | CVM |
|---|---|---|
| Price | $0.7308 | $1.37 |
| Market cap | $27.6M | $24.1M |
| Today | −7.49% | −0.72% |
| 1 month | −25.8% | −35.7% |
| 6 months | −48.5% | −14.4% |
| Year to date | −54.9% | −74.0% |
| 1 year | −68.1% | −80.6% |
| Revenue growth (YoY) | −103.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 2.0× | — |
| Net cash | $120.7M | $255.6K |
| Dividend yield | — | — |
| Volatility (60d) | 49.8% | 95.3% |
| Short % of float | 5.2% | 4.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).